Latest Headlines

  1. miRagen Therapeutics To Present New Clinical Trial Data For MRG-106, An Oligonucleotide Therapeutic Targeting microRNA-155, At The American Society Of Clinical Oncology Annual Meeting
    5/23/2017

    Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, announced today that new interim results from its ongoing Phase 1 clinical study of MRG-106 will be presented on June 5, 2017 at the American Society of Clinical Oncology (ASCO) Annual Meeting being held June 2-6, 2017 in Chicago, Illinois.

  2. JSR Life Sciences Expands Manufacturing Capabilities At KBI Biopharma
    5/23/2017

    JSR Life Sciences (JLS) recently announced that KBI Biopharma (KBI), a subsidiary of JSR Corporation (JSR), is expanding its biopharmaceutical manufacturing capacity and capabilities at both its Durham, North Carolina and Boulder, Colorado facilities.

  3. GE Healthcare’s FlexFactory To Power Dr. Reddy’s Biosimilar Expansion Plans
    5/18/2017

    GE Healthcare recently announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.

  4. Sartorius Stedim Biotech Partners With Nova Biomedical
    5/17/2017

    Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, recently announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile FLEX2 into the ambr multi-parallel bioreactor systems for automated, at-line cell culture analytics.

  5. Vivaldi Biosciences Appoints Manfred Reiter, PHD As Senior Vice President, Manufacturing
    5/16/2017

    Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenuated live influenza vaccines for seasonal and pandemic influenza, recently announced the appointment of Manfred Reiter, PhD as Senior Vice President, Manufacturing. Dr. Reiter has responsibility for Vero cell-based production of Vivaldi’s deltaFLU live attenuated influenza vaccines (LAIVs), including process optimization, scale-up, and manufacture in compliance with global quality standards.

  6. MilliporeSigma's CHOZN Expression System Selected By SystImmune
    5/16/2017

    MilliporeSigma, recently announced that its CHOZN expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.

  7. MilliporeSigma Launches Industry's First Off-The-Shelf Cell Culture Media For Perfusion Processes
    5/15/2017

    MilliporeSigma, recently took a significant step toward increasing manufacturing flexibility and enabling higher productivity with the launch of the EX-CELL Advanced HD Perfusion Medium. This first off-the-shelf, high-density cell culture media supports perfusion processes and facilitates high productivity at low perfusion rates, increasing production yield and speed to clinic.

  8. Outsourced Pharma Announces San Diego Forum Agenda Following Successful Boston Event
    5/8/2017

    Outsourced Pharma announced the agenda for its San Diego event at the conclusion of its Boston conference held this past April. An Early Start on Drug Development and Manufacturing Outsourcing is scheduled for August 22-23 at the Hyatt Regency La Jolla. The complete agenda and list of panelists can be found here.

  9. MilliporeSigma Collaborates With LabCentral To Foster Biotech Startups
    4/25/2017

    MilliporeSigma,announced recently that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts.

  10. Secretary Of Economic Development Of Puerto Rico Visits Sartorius
    4/25/2017

    Manuel Laboy, Secretary of Economic Development and Commerce of Puerto Rico, received first-hand information at Sartorius Goettingen headquarters about the expansion of its plant in Yauco, Puerto Rico. During a tour of Sartorius Campus, he was impressed by the high quality standards in the company’s research, development and manufacturing operations.